FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2888346301> ?p ?o ?g. }

• W2888346301 endingPage "1401" @default.
• W2888346301 startingPage "1394" @default.
• W2888346301 abstract "Abstract Background Fat accumulation and insulin resistance remain a threat to the success of antiretroviral therapy (ART). The role of gut dysfunction in metabolic complications associated with ART initiation is unclear. Methods Human immunodeficiency virus (HIV)-infected ART-naive participants were randomized to tenofovir disoproxil fumarate/emtricitabine plus atazanavir/ritonavir, darunavir/ritonavir, or raltegravir (RAL). Changes in the gut integrity markers zonulin, lipopolysaccharide-binding protein (LBP), and intestinal fatty acid and ileal bile acid binding proteins (I-FABP and I-BABP) were assessed over 96 weeks. Wilcoxon rank-sum tests were used to compare changes between groups and linear regression models to quantify associations between gut markers, insulin resistance, body mass index (BMI), and visceral, subcutaneous, and total adipose tissue (VAT, SAT, and TAT). Results : 90% were male and 48% were White non-Hispanic. The median age was 36 years, HIV-1 ribonucleic acid was 4.56 log10 copies/mL, and CD4 count was 338 cells/µL. An overall 1.7-fold increase in I-FABP was observed throughout 96 weeks, with no difference between arms. Zonulin levels increased with RAL compared to protease inhibitor–based regimens (week 96, P = .02); minimal changes in I-BABP or LBP levels were observed. Higher baseline I-FABP levels were associated with increases in VAT, TAT, and BMI (16%, 9%, and 2.5%, respectively; P < .04) over 96 weeks. Conclusions While ART induces changes in the markers of gut barrier dysfunction, the extent to which they improve or worsen the gut barrier function remains unclear. Nevertheless, markers of gut barrier dysfunction in ART-naive individuals predict increases in total and visceral abdominal fat with treatment initiation." @default.
• W2888346301 created "2018-08-31" @default.
• W2888346301 creator A5000167800 @default.
• W2888346301 creator A5027304381 @default.
• W2888346301 creator A5031633726 @default.
• W2888346301 creator A5064935269 @default.
• W2888346301 creator A5065731602 @default.
• W2888346301 creator A5067794846 @default.
• W2888346301 creator A5075228297 @default.
• W2888346301 creator A5084353681 @default.
• W2888346301 date "2018-08-23" @default.
• W2888346301 modified "2023-10-17" @default.
• W2888346301 title "Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral Therapy" @default.
• W2888346301 cites W1484294771 @default.
• W2888346301 cites W1925840058 @default.
• W2888346301 cites W1965977455 @default.
• W2888346301 cites W1978804351 @default.
• W2888346301 cites W1988314455 @default.
• W2888346301 cites W1992719447 @default.
• W2888346301 cites W2002980979 @default.
• W2888346301 cites W2007780373 @default.
• W2888346301 cites W2009563911 @default.
• W2888346301 cites W2029897159 @default.
• W2888346301 cites W2030793078 @default.
• W2888346301 cites W2047542844 @default.
• W2888346301 cites W2075711155 @default.
• W2888346301 cites W2088968901 @default.
• W2888346301 cites W2098152094 @default.
• W2888346301 cites W2098836196 @default.
• W2888346301 cites W2120264503 @default.
• W2888346301 cites W2131536322 @default.
• W2888346301 cites W2131691531 @default.
• W2888346301 cites W2132557478 @default.
• W2888346301 cites W2156358568 @default.
• W2888346301 cites W2160234571 @default.
• W2888346301 cites W2167028239 @default.
• W2888346301 cites W2169264636 @default.
• W2888346301 cites W2214717963 @default.
• W2888346301 cites W2256545526 @default.
• W2888346301 cites W2300191333 @default.
• W2888346301 cites W2311215932 @default.
• W2888346301 cites W2313780876 @default.
• W2888346301 cites W2320989354 @default.
• W2888346301 cites W2488768059 @default.
• W2888346301 cites W2526154361 @default.
• W2888346301 cites W2531567355 @default.
• W2888346301 cites W2532623505 @default.
• W2888346301 cites W2587727241 @default.
• W2888346301 cites W2589922704 @default.
• W2888346301 cites W2593834096 @default.
• W2888346301 cites W2606470721 @default.
• W2888346301 cites W2607031541 @default.
• W2888346301 cites W2736897448 @default.
• W2888346301 cites W769942964 @default.
• W2888346301 doi "https://doi.org/10.1093/cid/ciy716" @default.
• W2888346301 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6599164" @default.
• W2888346301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30137242" @default.
• W2888346301 hasPublicationYear "2018" @default.
• W2888346301 type Work @default.
• W2888346301 sameAs 2888346301 @default.
• W2888346301 citedByCount "21" @default.
• W2888346301 countsByYear W28883463012019 @default.
• W2888346301 countsByYear W28883463012020 @default.
• W2888346301 countsByYear W28883463012021 @default.
• W2888346301 countsByYear W28883463012022 @default.
• W2888346301 countsByYear W28883463012023 @default.
• W2888346301 crossrefType "journal-article" @default.
• W2888346301 hasAuthorship W2888346301A5000167800 @default.
• W2888346301 hasAuthorship W2888346301A5027304381 @default.
• W2888346301 hasAuthorship W2888346301A5031633726 @default.
• W2888346301 hasAuthorship W2888346301A5064935269 @default.
• W2888346301 hasAuthorship W2888346301A5065731602 @default.
• W2888346301 hasAuthorship W2888346301A5067794846 @default.
• W2888346301 hasAuthorship W2888346301A5075228297 @default.
• W2888346301 hasAuthorship W2888346301A5084353681 @default.
• W2888346301 hasBestOaLocation W28883463012 @default.
• W2888346301 hasConcept C126322002 @default.
• W2888346301 hasConcept C134018914 @default.
• W2888346301 hasConcept C142462285 @default.
• W2888346301 hasConcept C203014093 @default.
• W2888346301 hasConcept C2777391703 @default.
• W2888346301 hasConcept C2778414717 @default.
• W2888346301 hasConcept C2779182219 @default.
• W2888346301 hasConcept C2779298103 @default.
• W2888346301 hasConcept C2779306644 @default.
• W2888346301 hasConcept C2779778239 @default.
• W2888346301 hasConcept C2780221984 @default.
• W2888346301 hasConcept C2780404665 @default.
• W2888346301 hasConcept C2781071285 @default.
• W2888346301 hasConcept C2993143319 @default.
• W2888346301 hasConcept C3013748606 @default.
• W2888346301 hasConcept C539455810 @default.
• W2888346301 hasConcept C71924100 @default.
• W2888346301 hasConcept C90924648 @default.
• W2888346301 hasConceptScore W2888346301C126322002 @default.
• W2888346301 hasConceptScore W2888346301C134018914 @default.
• W2888346301 hasConceptScore W2888346301C142462285 @default.
• W2888346301 hasConceptScore W2888346301C203014093 @default.

• next